A Phase I, Pharmacokinetic And Biologic Correlative Study Of G3139 (Bcl-2 Antisense Oligonucleotide) And Docetaxel In Patients With Hormone-Refractory Prostate Cancer (Hrpc).
CLINICAL CANCER RESEARCH（2000）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要